Clinical Trials on Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant in Spain

Total 10 results

Novartis Pharmaceuticals

Completed

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study. (MAXIMIZA)

Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft

Spain
Hospital Vall d'Hebron

Completed

Human Microbiota and Liver Transplant

Infection | Intestinal Microbiota | Complication of Transplanted Liver | Acute Rejection of Liver Transplant

Spain
Fundación Pública Andaluza para la Investigación...
Sociedad Andaluza de Trasplantes de Organos y Tejidos

Completed

Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients

Renal Transplant Rejection | Other Complication of Kidney Transplant

Spain
Pfizer

Completed

Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

Renal Transplant | Graft Rejection | Kidney Transplant | Renal Allograft Recipients

United States, Australia, Germany, Italy, Spain, Brazil, Argentina
Novartis Pharmaceuticals

Completed

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Germany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
Neovii Biotech
Eurotrials Brasil Consultores Cientificos Ltda; Recerca Clínica S.L.; PsyConsult

Terminated

Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids (IBERICA)

Renal Transplant Rejection

Spain, Portugal
Tuberculosis Network European Trialsgroup

Unknown

New Generation IGRA in Immunocompromised Individuals (TBnet#54)

Active Tuberculosis | Monitoring, Immunologic | Tuberculosis in Solid Organ Transplant Recipients | Tuberculosis in Marrow Transplant Recipients | Tuberculosis in Rheumatoid Arthritis | Tuberculosis in Chronic Renal Failure | Tuberculosis in HIV-infected Individuals

Denmark, Germany, Italy, Moldova, Republic of, Norway, Poland, Portugal, Romania, Spain, United Kingdom
Predict4Health

Active, not recruiting

Clinical Impact of the iBox as an Early Intervention tooL (CIBIL)

Kidney Diseases | Kidney Failure, Chronic | Kidney Transplant Rejection | Kidney Disease, Chronic | Kidney Failure | Kidney Transplant; Complications | Kidney Dysfunction

Spain, United Kingdom, Austria, France, Germany, Israel
PETHEMA Foundation

Completed

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Acute Myeloid Leukemia | Allogeneic Haematopoietic Progenitor Cell Transplant

Spain
Atara Biotherapeutics

Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

Lymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditions

United States, Austria, Belgium, France, Italy, Spain, United Kingdom

Clinical Trials on Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations